chr8-89955280-G-C

Variant summary

Our verdict is Uncertain significance.
0 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 0 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_SupportingB3_Supporting

The NM_002485.5(NBN):c.1397+3C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The gene NBN is a tumor suppressor gene (CancerMine: 5 TSG citations). The variant allele was found at a cumulative frequency of 0.00000434 (AC=7) in the gnomAD database across 1,612,988 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000132. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

NBN
NM_002485.5 splice_region, intron

Scores

3
Splicing: ADA: 0.00002728
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 0.995

Publications

0 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Natera, Orphanet, G2P, Myriad Women's Health, ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: Natera
  • hereditary breast carcinoma
    Inheritance: Unknown, AD Classification: NO_KNOWN Submitted by: Natera, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002485.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 0 points.

O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000013 — very rare (O3 supporting [+1])
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Splice-region variant — splicing algorithms predict no impact on splicing; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_002485.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

NBN NM_002485.5
MANE Select
HGVSc / HGVSpc.1397+3C>G
Exon rankIntron 10 of 15
splice_regionintron
Prot: NP_002476.2
NBN NM_001024688.3
HGVSc / HGVSpc.1151+3C>G
Exon rankIntron 11 of 16
splice_regionintron
Prot: NP_001019859.1UniProt: A0A0C4DG07
NBN NM_001440379.1
HGVSc / HGVSpc.1151+3C>G
Exon rankIntron 10 of 15
splice_regionintron
Prot: NP_001427308.1UniProt: A0A0C4DG07

Ensembl Transcripts

NBN ENST00000265433.8
TSL:1MANE Select
HGVSc / HGVSpc.1397+3C>G
Exon rankIntron 10 of 15
splice_regionintron
Prot: ENSP00000265433.4UniProt: O60934
NBN ENST00000697309.1
HGVSc / HGVSpc.1397+3C>G
Exon rankIntron 10 of 14
splice_regionintron
Prot: ENSP00000513244.1UniProt: A0A8V8TKY5
NBN ENST00000697293.1
HGVSc / HGVSpc.1397+3C>G
Exon rankIntron 10 of 16
splice_regionintron
Prot: ENSP00000513230.1UniProt: A0A8V8TM80

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.0000132
AC:2
Hom:0
AN:151940
Cov:32
GnomAD4 exome
AF: 0.00000342
AC:5
Hom:0
AN:1461048
Cov:32
GnomAD4 genome
AF: 0.0000132
AC:2
Hom:0
AN:151940
Cov:32
TOPMed (Bravo)
AF: 0.0000113
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000524
AC:2
Hom:1
AN:38198
Showing 5 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.00 067850 0.00000750 1133284
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
Microcephaly, normal intelligence and immunodeficiency (3)
-
1
1
Hereditary cancer-predisposing syndrome (2)

Computational Scores

AlphaGenome AVI
Benign9.7
BayesDel_noAF
Benign-0.57
CADD
Benign10
DANN
Benign0.58
GPN-Star LLR
N/A-2.8
GPN-Star score
N/A2.8
PhyloP100
Benign0.99
Showing 7 of 7 scores

Splicing Scores

dbscSNV1_ADA
Benign0.000027
dbscSNV1_RF
Benign0.028
Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 4 of 4 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.